newsfilter
← Latest News
GlobeNewswire·

Imara to Present at Upcoming Investor Conferences

BOSTON, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (NASDAQ:IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglob